Quantcast

Alzheimer’s Drug Pipeline Calls for Lowered Expectations and Extreme Patience

October 2, 2013

Pharmaceutical research companies are now investigating or developing 81 Alzheimer’s drugs.* A blockbuster treatment for moderate to severe Alzheimer’s is still more than ten years away according to Rolando Hernandez neurosurgeon for Neurological Wellness Center.

(PRWEB) October 02, 2013

Pharmaceutical research has banked heavily on the beta amyloid hypothesis. The recent failures of bapineuzumab and solanezumab in phase III clinical trials has forced researchers to question weather reducing levels of amyloid in individuals with moderate Alzheimer’s will do any good. Research funds are increasingly being redirected from diagnosed groups and are now being focused on therapies that can prevent the disease or treat it in the very early stages.** “Setbacks in Alzheimer’s research are disappointing to many, including the scientists carrying out the studies, but these unsuccessful attempts are critical stepping stones to advancing our understanding of this extremely complex disease,” said PhRMA President and CEO John J. Castellani.

Since 2010, Neurological Wellness Center physicians have been reversing Alzheimer's disease, restoring memory, mood and cognitive functions in hundreds of patients utilizing the treatment detailed in Perispinal etanercept: a new therapeutic paradigm in neurology by Dr. Tobinick. This has enabled some severely impaired persons needing full time assisted living care who are unable to recognize their own children or even count to ten to, after a series of twelve doses over twelve weeks, to recognize their children and count to ten with ease. This restoration of memory and cognitive functions continues to build during the series of injections. “After three months of weekly injections, this individual may be able to regain the degree of independence and the lifestyle that they enjoyed up to three years earlier,” said Rolando Hernandez, M.D.

The 12-week therapeutic treatment regimen that Neurological Wellness Center physician Rolando Hernandez, M.D., advises will cost about $800 per month for the prescription drugs. The good news is that drugs usually are included in Medicare plans. “Although there are a wide range of treatment outcomes, most people with Alzheimer’s will need just one dose every 10 to 14 days long term to maintain stable function. This will cost on a cash pay basis $450 to $625 per month,” said Dr. Hernandez. Perispinal injections of etanercept (Enbrel) restore cognitive functions by reducing inflammation in the brain.

The drug needed to facilitate this reversal of Alzheimer’s disease and enabling a life-changing recovery of memory and cognitive function is the widely-prescribed, heavily-advertised Amgen/Pfizer drug Enbrel. Enbrel is most commonly prescribed as a treatment for rheumatoid arthritis, an inflammatory disease of the joints. “Many of the impairments experienced by people withAlzheimer’s disease are caused by excess inflammation in the brain. Once this excess inflammation is attenuated, the individual experiences a rapid recovery. This recovery extends to memory, mood, speech and physical function,” states Dr. Hernandez.

Why has mainstream media failed to report on this amazing breakthrough? Actually they have but only to a limited extent. The TV show 60 Minutes ran an excellent piece featuring a remarkable recovery of an Australian man with Alzheimer’s in October 2011.*** This show has aired in Australia and New Zealand but not in the United States.

For injections of Enbrel to be effective, they must be administered to the soft fatty tissue in the back of the neck between cervical vertebrae C-5 and C-6. This simple subcutaneous injection, performed with the same fine gauge ½ inch needle that all Enbrel users use. This injection is referred to as a perispinal injection. Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment, covering all aspects of perispinal injection technique at their center in Managua, Nicaragua.

For many, flying to Neurological Wellness Center in Managua, Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com. By following the instructions in the video lay caregivers and family members can learn to administer this injection.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua, Nicaragua, authorized this press release.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. For Enbrel to effectively treat Alzheimer’s, it must be administered to the back of the neck precisely between the cervical vertebrae. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. Fortunately for the millions of people now afflicted with Alzheimer’s, a video is now available online detailing in step-by-step fashion, how to administer a perispinal injection of Enbrel,” said Dr. Rolando Hernandez. To order the 24 minute perispinal Enbrel instructional video and accompanying 37 page e-book visit: http://www.neurological-recovery-guide.com/

*.phrma.org/research/medicines-development-alzheimers-disease

**.phrma.org/media/releases/setbacks-stepping-stones-alzheimers-disease

*** http://sixtyminutes.ninemsn.com.au/videoindex.aspx?uuid=56ae56c3-f541-4fa4-a2ad-86a6b1e0af7d

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11170032.htm


Source: prweb



comments powered by Disqus